agilon health Past Earnings Performance
Past criteria checks 0/6
agilon health's earnings have been declining at an average annual rate of -4.1%, while the Healthcare industry saw earnings growing at 5.7% annually. Revenues have been growing at an average rate of 38.6% per year.
Key information
-4.1%
Earnings growth rate
1.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 38.6% |
| Return on equity | -54.1% |
| Net Margin | -5.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Further Upside For agilon health, inc. (NYSE:AGL) Shares Could Introduce Price Risks After 29% Bounce
Jan 14
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 10agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Nov 08Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Oct 15agilon health: Interesting Business Model, But Volatile And Uncertain
Aug 16Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower
Aug 16Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Jul 15The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More
Jun 06agilon health: Still Not Healthy Enough To Warrant Upside
Apr 19Is agilon health (NYSE:AGL) Using Too Much Debt?
Apr 04agilon health: High Growth But Unsustainable Economics
Nov 20agilon health: Strong Sales Growth, Lacks Remaining Value Drivers
Sep 13Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues
Jul 17agilon health: A Hold Until Margins Are Improved
Jun 30An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued
Jun 06Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?
Apr 28Revenue & Expenses Breakdown
How agilon health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 5,594 | -311 | 269 | 0 |
| 30 Jun 24 | 5,280 | -217 | 280 | 0 |
| 31 Mar 24 | 4,866 | -202 | 290 | 0 |
| 31 Dec 23 | 4,316 | -195 | 286 | 0 |
| 30 Sep 23 | 3,630 | -69 | 285 | 0 |
| 30 Jun 23 | 3,188 | -78 | 265 | 0 |
| 31 Mar 23 | 2,789 | -83 | 237 | 0 |
| 31 Dec 22 | 2,388 | -92 | 206 | 0 |
| 30 Sep 22 | 2,481 | -108 | 195 | 0 |
| 30 Jun 22 | 2,245 | -114 | 185 | 0 |
| 31 Mar 22 | 2,074 | -391 | 451 | 0 |
| 31 Dec 21 | 1,521 | -384 | 422 | 0 |
| 30 Sep 21 | 1,692 | -387 | 438 | 0 |
| 30 Jun 21 | 1,546 | -363 | 429 | 0 |
| 31 Mar 21 | 1,340 | -69 | 147 | 0 |
| 31 Dec 20 | 1,218 | -63 | 137 | 0 |
| 30 Sep 20 | 1,095 | -59 | 127 | 0 |
| 31 Dec 19 | 794 | -114 | 123 | 0 |
Quality Earnings: AGL is currently unprofitable.
Growing Profit Margin: AGL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AGL is unprofitable, and losses have increased over the past 5 years at a rate of 4.1% per year.
Accelerating Growth: Unable to compare AGL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AGL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.2%).
Return on Equity
High ROE: AGL has a negative Return on Equity (-54.1%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/03 04:49 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
agilon health, inc. is covered by 30 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hua Ha | Baird |
| Andrew Mok | Barclays |
| William Sutherland | Benchmark Company |